Screening with a PSA test has a small impact on prostate cancer deaths but leads to overdiagnosis6 April 2024The largest study to date investigating a single invitation to a PSA blood test to screen for prostate cancer has found it had a small impact on reducing deaths, but also led to overdiagnosis and missed early detection of some aggressive cancers. The CAP trial, published in the Journal of the American Medical Association (JAMA) and carried out by researchers from the universities of Bristol, Oxford and Cambridge, involved over 400,000 men aged 50-69. Just under half received a single invitation for a PSA test as part of the trial.
Patient recovery after surgery for oesophageal cancer isn’t influenced by using standard or keyhole incisions26 March 2024New research has found no evidence of a difference between recovery time and complications when comparing standard and keyhole surgical incisions for the treatment of oesophageal cancer (cancer of the gullet). The study, led by the University of Bristol Medical School and published in the British Journal of Surgery, showed surgeons treating patients with oesophageal cancer do not need to change their practice if they have a strong preference for either procedure type.
New cancer and domestic abuse toolkit launched26 March 2024A new toolkit to support cancer professionals to identify and respond to signs of domestic abuse in patients with cancer and their carers is being launched today [26 March]. The toolkit has been developed in partnership with the University of Bristol, Standing Together Against Domestic Abuse, and Macmillan Cancer Support.
Bristol leaps ahead in training next generation of leaders to tackle major global challenges12 March 2024Hundreds of talented scientists and engineers are set to advance solutions for some of the world’s most pressing challenges, ranging from reaching net-zero and developing sustainable energy to improving digital security and making the latest health breakthroughs.
New Digital Health Hub launches in South West England and Wales11 March 2024A consortium of universities from across the South West of England and Wales have come together to form a brand new Digital Health Hub which will elevate the region’s digital health capability through leadership, engagement, acceleration and partnership (LEAP).
Anti-diabetic drugs could lower risk of primary and secondary brain cancer22 February 2024Diabetic patients who take anti-diabetic drugs - known as glitazones – long term had a lower risk of primary and secondary brain cancer compared with diabetic patients on other medications, new research led by the University of Bristol has found.
Fakes, facts, society and health8 February 2024The Elizabeth Blackwell Institute for Health Research welcomed Patricia Kingori, Professor of Global Health Ethics at the University of Oxford, as their 10th Annual Public Lecture speaker.
Weight loss intervention in people with type 2 diabetes influences cancer-associated proteins30 January 2024A weight loss intervention in people with type 2 diabetes was found to alter levels of cancer-related proteins, according to the findings of a new University of Bristol-led study. The study is the first to show that weight loss in people recently diagnosed with diabetes can change the levels of cancer-related chemicals circulating in the blood.
Wellcome Trust Awards £3.1 Million to Bristol Researcher for Stem Cell Biology Research8 January 2024Dr. Bethan Lloyd-Lewis, a Vice-Chancellor’s Research Fellow at the School of Cellular and Molecular Medicine (CMM), has been awarded a £3.1 million fellowship from the Wellcome Trust to lead research into the regulatory mechanisms influencing stem cell fate decisions during organ development and cancer.